Tiffany Crowell

Tiffany Crowell joined Acrivon in April of 2026 as SVP of Clinical Operations. Tiffany has over 30 years of experience in oncology, building and leading clinical operations teams. She has demonstrated leadership overseeing global clinical trials, developing strategic partnerships, and ensuring regulatory compliance. Tiffany has expertise in the optimization of trial execution, building effective teams, and managing relationships with internal and external stakeholders to drive clinical development initiatives. Prior to Acrivon, Tiffany led the clinical operations group at Syndax overseeing multiple sponsored and collaborative clinical trials in the AML and GVHD space. Prior to joining Syndax, from 2018 to 2025, Tiffany was leading clinical operations, data management, and sample management team across multiple programs for APL, selected solid tumors, AML and MDS at Syros Pharmaceuticals. Earlier in her career, Tiffany held clinical operations positions of increasing responsibilities at Merrimack, Cerulean Pharma, AVEO, Inotek, and Vertex. She holds a B.S. in Chemistry from Randolph College in Virgina.